| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $38.07B | +9.0% |
| Cost of Revenue | $30.53B | +5.8% |
| Gross Profit | $7.54B | +23.8% |
| R&D Expense | $1.20B | +21.9% |
| SG&A Expense | $4.95B | +6.8% |
| Operating Income | $1.39B | +194.7% |
| Pre-tax Income | $2.83B | +13.2% |
| Income Tax | -$2.05B | -318.4% |
| Net Income | $4.88B |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $9.80B | +19.9% |
| Inventory | $10.43B | +21.5% |
| Current Assets | $40.22B | +17.8% |
| Total Assets | $63.02B | +22.4% |
| Current Liabilities | $40.97B | +29.3% |
| Total Liabilities | $50.72B | +24.0% |
| Stockholders' Equity | $11.18B | +17.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $4.99B | +93.1% |
| Investing Cash Flow | -$755.0M | -1940.5% |
| Financing Cash Flow | -$3.81B | -204.4% |
| +214.7% |
| EPS (Basic) | $17.92 | +217.2% |
| EPS (Diluted) | $17.69 | +217.0% |